Alvotech Reykjavik News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The regulator issued a Complete Response Letter citing “deficiencies” at the company’s Reykjavik plant, this time for its Stelara biosimilar AVT04. It’s the fourth FDA rejection for Alvotech since last year.

United statesJohnson stelaraRobert wessmanTeva pharmaceuticalsComplete response letterBiologics license applicationAlvotech reykjavikDa rejects alvotechs stelara biosimilar as manufacturing problems continue